Filing Flows

Filing Flows › Zimmer Biomet Holdings (ZBH) › Q1 2026

Zimmer Biomet Holdings (ZBH) Q1 2026 earnings results (first quarter 2026)

10-Q filed May 1, 2026

Zimmer Biomet Holdings (ZBH) reported revenue of $2.1B for the first quarter 2026 (Q1 2026), +9% from a year earlier and -7% from the quarter before. Operating margin was 17.9%, net earnings $238M (11.4% of revenue).

Revenue$2.1B
Year over year+9%
Quarter over quarter-7%
Operating margin17.9%
Net earnings$238M

Zimmer Biomet Holdings, Q1 2026: revenue $2.1B (+9% year over year), operating margin 17.9%, net earnings $238M, operating cash flow $359M. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$2.1B-7%+9%
Operating profit$373M+142%+28%
Net earnings$238M+73%+31%
Operating cash flow$359M-31%-6%
Free cash flow$246M—-12%

What changed

Revenue was $2.1B in Q1 2026, up 9% year over year and down 7% from the previous quarter. Knees was the largest line at 40% of revenue. SET added $0.09B year over year (up 19%), 52% of the total change.

Operating profit was $0.37B, a 17.9% margin (up 2.6 points year over year). Of the extra revenue versus Q1 2025, 46% reached operating profit, above the 15% margin then. Total costs grew 6% against revenue growth of 9%. The fastest-growing cost line was SG&A (+12%). Net earnings were $0.24B, up 31% year over year. The effective tax rate was 20.9%.

Operating cash flow was $0.36B (down 6% year over year), 151% of net earnings. Non-cash charges added back $0.27B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.17B. After itions to instruments ($0.08B) and itions to other property, plant and equipment ($0.04B), free cash flow as the company reports it was $0.25B.

Questions

What was Zimmer Biomet Holdings' revenue in the first quarter 2026?

Zimmer Biomet Holdings (ZBH) reported revenue of $2.1B for the first quarter 2026 (Q1 2026), +9% from a year earlier and -7% from the quarter before.

Was Zimmer Biomet Holdings profitable in the first quarter 2026?

Operating profit was $373M (17.9% of revenue) and net earnings $238M.

Open the interactive Sankey →

Source: Zimmer Biomet Holdings 10-Q on SEC EDGAR.